Add Formweb to your mobile device
1/7/22 aa LR/D5W/D5NS IV Bolus Formulary Changes: Tuesday, Jan 11
January 10, 2022
From: "Aaron Atkins" <aaron.atkins@hhsys.org>
To: "Pharmacists" <grp_allpharm@hhsys.org>
Sent: Friday, January 7, 2022 2:28:32 PM
Subject: LR/D5W/D5NS IV Bolus Formulary Changes: Tuesday, Jan 11
Following this update on Tuesday earlier this week, we have not had any issues reported. Therefore, we will be updating Cerner to remove IV BOLUS duplicate products of LR, D5W, and D5NS on Tuesday, January 11.
Aaron B. Atkins, Pharm.D., BCPS
Clinical Pharmacist, Informatics Lead
Huntsville Hospital
(256)265-3276
From: Aaron Atkins [mailto:aaron.atkins@hhsys.org]
Sent: Thursday, December 30, 2021 10:49 AM
To: Pharmacists
Subject: Sodium Chloride 0.9% IV Bolus Formulary Changes: Tuesday, Jan 4
Effective Tuesday, January 4 we will be removing the duplicated sodium chloride 0.9% “IV Bolus” products from the formulary. You will no longer see these product options for Normal Saline appear when searching in MedManager.
After this change, orders for an IV Bolus route for these products will product assign to the ‘standard’ IV Soln products instead (order verification example below) which will still be treated as a Med Type (does not require a rate entered on the order).
Of note, after this change, if you are entering an order for one of the ‘standard’ IV Soln products directly into MedManager/PharmNET, you will be prompted to choose between Med/Intermittent/Continuous type. If the order is meant to be an IV BOLUS, please choose the MED type so that a rate is not required on the order.
Recall the appropriate order types and corresponding IV routes:
Medication Type: IV Push, IV Bolus, Slow IV Push
Intermittent Type: IV Piggyback, IV Syringe
Continuous Type: IV, IV Syringe-Cont
We are starting with Sodium Chloride 0.9% (NS) Bolus products first and will expand to remove other bolus products (D5W/LR) as long as no issues are experienced with this change.
If you have any questions or experience any issues following this change, please reach out to PharmIT Group. Thank you.